The Indian pharmaceutical sector is the world's third-biggest by volume and makes a substantial contribution to global health.
The Subject Expert Committee (SEC) under India's drug regulator turned down applications by Hetero Labs and Optimus Pharma to launch the generic version of Pfizer's Covid-19 antiviral drug paxlovid without local clinical trials. Both companies had ap
Renuka Ramnath-led private equity (PE) fund Multiples Alternate Asset Management will invest around ₹750 crore to take an about 10% stake in Mumbai-based generic drugs manufacturer BDR Pharmaceuticals, multiple people aware of the development said.ss
Novo Nordisk India has launched an oral formulation for an anti-diabetes drug that was available only as injections, and claimed the new drug can assist better control blood sugar levels and weight in adults with type-2 diabetes. Novo Nordisk India h
Drug discovery outsourcing to India is poised to get a major fillip as pharma companies are ramping up their R&D activities powered by the government's initiatives to endorse research in innovative drugs.
In today’s dynamic and quickly changing time, majority of pharmaceutical companies are scrambling to emerge on top and boost their performance without adding to their total cost of operations.
The government has built an expert committee to frame new laws for medicines, cosmetics and medical devices in a bid to replace the existing Drugs and Cosmetics Act which was formed in 1940.
India accomplished the one billion COVID-19 vaccinations milestone this morning. The government needs all of India's 944 million adults to get vaccinated this year.
Indian pharmaceutical industry is expected to become worth $130 billion by 2030, said Chemical and Fertilizer Minister D V Sadananda Gowda at the curtain raiser press conference on the 6th
The sales for Indian pharmaceutical companies are expected to log a robust growth in FY22, said Fitch Ratings.
, CDSCO.jpg)
